TCM
LUNG icon

TimesSquare Capital Management’s Pulmonx LUNG Stock Holding History

TimesSquare Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,223,754
Closed -$20.4M – 187
2022
Q3 		$20.4M Buy
1,223,754
+9,550
+0.8% +$176K 0.28% 139
2022
Q2 		$17.9M Buy
1,214,204
+140,300
+13% +$2.89M 0.25% 145
2022
Q1 		$26.6M Sell
1,073,904
-181,196
-14% -$4.68M 0.3% 131
2021
Q4 		$40.3M Sell
1,255,100
-17,730
-1% -$648K 0.36% 121
2021
Q3 		$45.8M Buy
1,272,830
+621,720
+95% +$24.5M 0.4% 106
2021
Q2 		$28.7M Buy
651,110
+299,110
+85% +$13M 0.24% 157
2021
Q1 		$16.1M Buy
352,000
+30,600
+10% +$1.76M 0.14% 185
2020
Q4 		$22.2M Buy
+321,400
New +$15.7M 0.18% 172

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

TimesSquare Capital Management's LUNG Position: Q4 2022 in Review

TimesSquare Capital Management sold out of Pulmonx (LUNG) in Q4 2022, closing a stake of 1,223,754 shares — an estimated $20.4M sold.

TimesSquare Capital Management first reported a position in LUNG in Q4 2020 and held it in 8 quarters. The position peaked at $45.8M in Q3 2021. 115 funds tracked by Wall St. Rank hold LUNG as of Q4 2022.

  • TimesSquare Capital Management reported no remaining Pulmonx position as of Q4 2022 after selling out during the quarter.
  • TimesSquare Capital Management sold 1,223,754 Pulmonx shares in Q4 2022, an estimated $20.4M.
  • TimesSquare Capital Management first reported a position in Pulmonx in Q4 2020 and held it in 8 quarters.
  • TimesSquare Capital Management's Pulmonx position peaked at $45.8M in Q3 2021.
  • 115 funds tracked by Wall St. Rank held Pulmonx as of Q4 2022.

Based on TimesSquare Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.